<DOC>
	<DOCNO>NCT01491542</DOCNO>
	<brief_summary>The purpose pilot clinical trial evaluate feasibility use investigational implant ( INFUSE® Bone Graft MASTERGRAFT® Granules CD HORIZON® Spinal System ) method facilitate spinal fusion patient symptomatic degenerative disc disease .</brief_summary>
	<brief_title>INFUSE® Bone Graft MASTERGRAFT® Granules With CD HORIZON® Posterolateral Lumbar Fusion Patients With Degenerative Disc Disease - Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>1 . Has degenerative disc disease note back pain discogenic origin , without leg pain , degeneration disc confirm patient history ( e.g. , pain [ leg , back , symptom sciatic nerve distribution ] , functional deficit and/or neurological deficit ) radiographic study ( e.g. , C T , MRl , XRay , etc . ) include one following : instability ( define angulation ≥ 5° and/or translation ≥ 4mm , base flexion/extension radiograph ) ; osteophyte formation ; decrease disc height ; thicken ligamentous tissue ; disc degeneration herniation ; and/or facet joint degeneration . 2 . Has preoperative Oswestry score ≥ 30 . 3 . Has great Grade 1 spondylolisthesis utilize Meyerding 's Classification ( Meyerding HW,1932 ) . 4 . Requires fusion single level disc space L1 S1 . 5 . Is least 18 year age , inclusive , time surgery . 6 . Has respond nonoperative treatment ( e.g. , bed rest , physical therapy , medication , spinal injection , manipulation , and/or TENS ) period 6 month . 7 . If childbearing potential , patient nonpregnant , nonnursing , agree use adequate contraception 1 year follow surgery . 8 . Is willing able comply study plan sign Patient Informed Consent Form . 1 . Has primary diagnosis spinal disorder degenerative disc disease Grade 1 less spondylolisthesis involve level . 2 . Had previous spinal fusion surgical procedure involve level adjacent level . 3 . Requires spinal fusion one lumbar level . 4 . Has condition require postoperative medication interfere fusion , steroid prolong use nonsteroidal antiinflammatory drug . This include low dose aspirin prophylactic anticoagulation . 5 . Has document history osteopenia osteomalacia . 6 . Has follow may associate diagnosis osteoporosis ( `` Yes '' risk factor , dual xray absorptiometry ( DEXA ) scan require determine eligibility . ) Postmenopausal nonblack female 60 year age weigh less 140 pound . Postmenopausal female sustain nontraumatic hip , spine , wrist fracture . Male age 70 . Male age 60 sustain nontraumatic hip spine fracture . If level BMD T score 3.5 T score 2.5 vertebral crush fracture , patient exclude study . 7 . Has presence active malignancy prior history malignancy ( except basal cell carcinoma skin ) . 8 . Has overt active bacterial infection , either local systemic . 9 . Has document titanium alloy allergy intolerance . 10 . Is mentally incompetent . If questionable , obtain psychiatric consult . 11 . Has 'Waddell Signs Inorganic Behavior'score 3 great . 12 . Is prisoner . 13 . Is alcohol and/or drug abuser define currently undergo treatment alcohol and/or drug abuse . 14. ls tobacco user time surgery . 15 . Has receive drug may interfere bone metabolism within two week prior plan date spinal fusion surgery ( e.g. , steroids methotrexate ) . 16 . Has document history autoimmune disease ( e.g . Systemic Lupus Erythematosus dermatomyositis ) . 17 . Has history exposure implant collagen silicone implant . 18 . Has history hypersensitivity protein pharmaceutical ( monoclonal antibody gamma globulin ) collagen . 19 . Has receive treatment investigational therapy within 28 day prior implantation surgery treatment plan 16 week follow rhBMP2/ACS/MASTERGRAFT® Granules implantation . 20 . Has receive previous exposure any/all BMP 's either human animal extraction . 21 . Has history allergy bovine product history anaphylaxis . 22 . Has history endocrine metabolic disorder know affect osteogenesis ( e.g. , Paget 's disease , renal osteodystrophy , Ehlers Danlos syndrome , osteogenesis imperfecta ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Symptomatic Degenerative Disc Disease</keyword>
</DOC>